PinPoint powered by PinSilico – physics and AI-enabled discovery
At the core of our discovery engine is PinPoint - a peptide-specific medicinal
chemistry approach designed to engineer drug-like properties into validated hits. PinPoint
combines structural biology with bespoke non-canonical amino acid design to identify and exploit
promising receptor interactions to transform a hit peptide into a candidate.
PinPoint is powered by PinSilico - a breakthrough suite of structure-based drug
design (SBDD) technologies that integrates physics-based simulations, emerging AI methodologies,
and scalable computational infrastructure. PinSilico allows rapid hit diversification and lead
optimization for tuning affinity and phys-chem properties. PinSilico includes PinFormatics and
PinScale as a foundation on which we have built PinFinity and PinNovo workflows with more on the
way.
De novo peptide design
PinNovo combines AI models for structure prediction, physics-based simulations and
automated non-canonical amino acid design to generate diverse site-specific cyclic peptide
binders with activity profile comparable with in vitro affinity based screening.
Binding optimization & structure refinement
PinFinity focuses on enhancing target engagement through iterative structure-guided
optimization. Using simulation-driven feedback loops, it refines binding affinity,
conformational stability, and interaction specificity.
Cheminformatics and data intelligence tailored to peptides
PinFormatics marries custom cheminformatics with experimental and computational data
streams, enabling seamless SAR analysis across sequence and chemical structure space, generating
insights from historical data and accelerating design.
Computational scale & workflow automation
PinScale is the high-performance distributed computing backbone of the whole
platform. Through automated workflows built on scalable compute infrastructure, it accelerates
DMTA cycles and the number of targets with SBDD-enabled series.